Identifying beneficial bacteria for gut health
Development of a high throughput in vivo screening platform for identifying novel pro-and postbiotic bacterial strains
['FUNDING_SBIR_1'] · NEMALIFE INC. · NIH-10823009
This study is looking for new types of bacteria that can help improve gut health by testing them in a tiny worm, making it faster and easier to find effective probiotics and supplements for you.
Quick facts
| Phase | ['FUNDING_SBIR_1'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEMALIFE INC. (nih funded) |
| Locations | 1 site (LUBBOCK, UNITED STATES) |
| Trial ID | NIH-10823009 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a high-throughput screening platform to identify novel bacterial strains that can improve gut health. By utilizing a model organism called Caenorhabditis elegans, the study aims to efficiently test various bacterial isolates for their potential health benefits. The approach seeks to overcome the challenges of traditional methods that are slow and costly, thereby accelerating the discovery of effective probiotics and postbiotics for dietary supplementation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing gut health issues or neurodegenerative diseases, particularly those related to Alzheimer's.
Not a fit: Patients with no gut health concerns or those not affected by neurodegenerative diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new dietary supplements that improve gut health and potentially alleviate conditions like Alzheimer's disease and other health disorders linked to gut dysbiosis.
How similar studies have performed: Previous research has shown promise in using similar high-throughput screening methods to identify beneficial bacteria, indicating a potential for success in this novel approach.
Where this research is happening
LUBBOCK, UNITED STATES
- NEMALIFE INC. — LUBBOCK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: QURESHI, MOHAMMED ADNAN MOHAMMED HANIF — NEMALIFE INC.
- Study coordinator: QURESHI, MOHAMMED ADNAN MOHAMMED HANIF
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease